Kerala Ayurveda Ltd. Approves Private Placement of Non-Convertible Debentures

Kerala Ayurveda Ltd. Approves Private Placement of Non-Convertible Debentures

Kerala Ayurveda Ltd. Approves Private Placement of Non-Convertible Debentures​

Kerala Ayurveda Ltd. announced on March 25, 2026, that its Board of Directors approved the issuance of 4,000 Series 'A' unlisted, secured, and redeemable Non-Convertible Debentures (NCDs). Each NCD has a face value of Rs. 1,00,000, totaling an aggregate amount of Rs. 40,00,00,000. The issuance will occur on a private placement basis.

The borrowing is within limits previously approved by the company's shareholders on August 22, 2025. The Board meeting commenced at 11:00 am and concluded at 12:10 pm.

Key details of the NCD issuance are outlined below:

ParticularsDisclosures
1Type of securitiesSeries 'A' unlisted, secured and redeemable Non-Convertible Debentures
2Type of issuancePrivate placement
3Total Number of Securities and aggregate amount4,000 NCDs with an aggregate amount of Rs. 40,00,00,000
4Size of the IssueRs. 40,00,00,000
5Listing StatusNot listed
6Tenure of the instrumentUpto 10 years
7Allotment and Maturity DatesAllotment within 1 month; maturity after a moratorium of 24 months (2 years) followed by 32 quarterly instalments.
8Coupon/Interest Rate12% p.a. on reducing balance year to year.
9Payment ScheduleQuarterly interest payments; principal through a moratorium of 24 months (2 years) followed by 32 quarterly instalments.
10Charge/SecurityFirst Charge on Industrial Property (Factory Land & Building and Plant & Machinery) located at Kerala Ayurveda Ltd., Survey No. 264/1, 264/26, 264/27, Near St. Francis Assisi Church, Airport Road, Nedumbassery, Village Chengamanad, Taluka Aluva, Dist - Ernakulam, Kerala - 683585.
11Special Rights/PrivilegesNot Applicable
12Default Penalties2%
13Comments on Payment/Non-PaymentNil
14Redemption DetailsMoratorium of 24 months (2 years) followed by 32 quarterly instalments.
15Cancellation/TerminationNot Applicable

Source:​

 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Back
Top